Tripathi Aashutosh, Donkin Ryan W, Miracle Joy S, Murphy Robert D, Gentry Matthew S, Patwardhan Abhijit, Sinai Anthony P
Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA.
bioRxiv. 2024 Oct 31:2024.09.02.610794. doi: 10.1101/2024.09.02.610794.
The contribution of amylopectin granules (AG), comprised of a branched chain storage homopolymer of glucose, to the maintenance and progression of the chronic infection has remained undefined. Here we describe the role of AG in the physiology of encysted bradyzoites by using a custom developed imaging-based application AmyloQuant that permitted quantification of relative levels of AG within derived tissue cysts during the initiation and maturation of the chronic infection. Our findings establish that AG are dynamic entities, exhibiting considerable heterogeneity among tissue cysts at all post infection time points examined. Quantification of relative AG levels within tissue cysts exposes a previously unrecognized temporal cycle defined by distinct phases of AG accumulation and utilization over the first 6 weeks of the chronic phase. This AG cycle is temporally coordinated with overall bradyzoite mitochondrial activity implicating amylopectin in the maintenance and progression of the chronic infection. In addition, the staging of AG accumulation and its rapid utilization within encysted bradyzoites was associated with a burst of coordinated replication. As such our findings suggest that AG levels within individual bradyzoites, and across bradyzoites within tissue cysts may represent a key component in the licensing of bradyzoite replication, intimately linking stored metabolic potential to the course of the chronic infection. This extends the impact of AG beyond the previously assigned role that focused exclusively on parasite transmission. These findings force a fundamental reassessment of the chronic infection, highlighting the critical need to address the temporal progression of this crucial stage in the parasite life cycle.
由葡萄糖的支链储存均聚物组成的支链淀粉颗粒(AG)对慢性感染的维持和进展的贡献仍不明确。在此,我们通过使用定制开发的基于成像的应用程序AmyloQuant来描述AG在包囊缓殖子生理学中的作用,该程序能够在慢性感染的起始和成熟过程中对源自组织囊肿的AG相对水平进行定量。我们的研究结果表明,AG是动态实体,在所检查的所有感染后时间点的组织囊肿之间表现出相当大的异质性。对组织囊肿内相对AG水平的定量揭示了一个以前未被认识到的时间周期,该周期由慢性期前6周内AG积累和利用的不同阶段定义。这个AG周期在时间上与整体缓殖子线粒体活性相协调,这意味着支链淀粉在慢性感染的维持和进展中起作用。此外,AG在包囊缓殖子内的积累阶段及其快速利用与一阵协调的复制有关。因此,我们的研究结果表明,单个缓殖子内以及组织囊肿内的缓殖子之间的AG水平可能代表缓殖子复制许可的一个关键组成部分,将储存的代谢潜力与慢性感染的进程紧密联系起来。这将AG的影响扩展到了以前仅专注于寄生虫传播的作用之外。这些发现迫使对慢性感染进行根本性的重新评估,突出了迫切需要解决寄生虫生命周期中这一关键阶段的时间进展问题。